Richard's Whole Foods  
10% Off Register online today and receive 10% off your next in-store purchase.
Your E-mail:     
Healthy Recipes Reference Library Store Specials About Us Friday, May 05, 2006
Search Site
Reference Library
Sign In
My Account
Contact Us
Shopping Cart

Table of Contents > Conditions > Myocardial Infarction
Myocardial Infarction
Also Listed As:  Heart Attack
Signs and Symptoms
Risk Factors
Preventive Care
Treatment Approach
Nutrition and Dietary Supplements
Massage and Physical Therapy
Mind/Body Medicine
Other Considerations
Prognosis and Complications
Supporting Research

The technical name for heart attack is myocaridal infarction (MI). The heart is a large muscle responsible for pumping blood, which carries oxygen, to every organ in the body including the heart itself. A heart attack occurs when an artery leading to an area of the heart becomes completely blocked. This blockage leads to the death of heart muscle cells in that area.

A heart attack is a medical emergency. Seek immediate medical attention if you or someone you are with is having the symptoms listed in the section below. .

If treatment is sought promptly, lives can be saved and threatened heart muscle can be salvaged. This prevents as much damage to the heart and preserves as much function as possible.

Signs and Symptoms
  • Pain, heaviness, tightness, burning—in chest, back, left arm, jaw, neck
  • Difficulty breathing
  • Dizziness, weakness
  • Nausea, vomiting
  • Irregular heartbeat


Atherosclerosis is plaque that builds up in arteries throughout the body, including coronary (heart) blood vessels, over time. Many factors, such as high LDL ("bad") chyolesterol contribute to the development of plaque. Most heart attacks are caused by a combination of the following:

  • A blood clot that blocks one of the coronary arteries (the blood vessels that bring blood and oxygen to the heart muscle)
  • Rupture of unstable plaque (atherosclerosis)
  • "Endothelial dysfunction"

Endothelial cells line the inner wall of coronary blood vessels. When these cells become disturbed (from, for example, eating a high fat meal, sudden stress, or high blood pressure), a piece of atherosclerotic plaque can dislodge and land in a narrow section of a coronary artery. When this happens, blood flow is blocked and can cause severe chest pain or even a heart attack. Atherosclerosis, plaque rupture, and endothelial dysfunction can also stimulate the formation of a blood clot which, in turn, interrupts blood flow and leads to a heart attack.

When a coronary artery is blocked the lack of blood and oxygen to the heart muscle leads to the death of heart cells in that area. The damaged heart muscle loses its ability to contract, and the remaining intact heart muscle needs to compensate for that area of weakness.

Endothelial dysfunction seems to be related to reduced levels of a substance called nitric oxide. Normal levels and function of nitric oxide help the coronary blood vessels relax and dilate (widen). When these vessels are relaxed, there is more blood flow to the heart. Oxidative stress (a normal but damaging metabolic process in the body exacerbated by environmental factors such as exposure to cigarette smoke and pollutants) reduces the availability and function of nitric oxide, thereby reducing the ability of the coronary blood vessels to relax. In theory, therefore, antioxidants (like carotenoids and vitamins C and E) in the diet or possibly from supplements may improve amounts and function of nitric oxide. This, in turn, improves blood flow and reduces the chances of a heart attack. (See Nutrition and Dietary Supplements.)

Risk Factors

Occasionally, sudden overwhelming stress can trigger a heart attack. Other common risk factors include:

  • Smoking
  • High-fat diet
  • Poor blood cholesterol levels, especially high LDL ("bad") cholesterol and low HDL ("good") cholesterol as well as elevated triglycerides
  • Family history of early MI
  • Diabetes
  • High blood pressure
  • Being male, or a female who has gone through menopause
  • Being overweight/obese (which also increases your risk for having high cholesterol, diabetes, and high blood pressure)
  • Sedentary lifestyle

Additional risk factors for coronary artery disease include elevated homocysteine, C-reactive protein (CRP), lipoprotein (a), and fibrinogen levels. CRP and fibrinogen are markers of inflammation. There is some thought that chronic infection may be involved in the development of atherosclerosis and the risk of having a heart attack. Lots of research in these areas is currently underway.

If you have had a heart attack and you have a high homocysteine level, the likelihood of a bad outcome (like another heart attack or even death) is greather than for those with a normal or low homocysteine level. High homocysteine can be treated with folic acid (see ).

Use of birth control pills, cocaine, or amphetamines may also increase your chances for a heart attack. And, certain psychological factors, listed below, have been linked to heart attacks and a worse outcome from a heart attack:

  • Depression
  • Anger and hostility
  • Social isolation and lack of social support
  • Chronic (ongoing) stress

It is now known whether treatment of these conditions and change of such situations will lessen your chances for a first time or repeat heart attack. However, it certainly seems reasonable to work on addressing these feelings and circumstances.


If you think that you are having a heart attack, call for medical assistance immediately. Treating a heart attack within 90 minutes can save your life. In the emergency room, a health care provider will ask you about your symptoms and perform a physical examination.

The following tests may reveal a heart attack and the extent of heart damage:

  • Electrocardiogram (ECG) -- single or repeated over several hours
  • Echocardiography
  • Nuclear ventriculography (MUGA or RNV)

The following tests may show the by-products of heart damage from a heart attack:

  • Troponin I and troponin T
  • CK and CK-MB

Coronary angiography (a procedure to look at your coronary blood vessels) may be necessary to assess and treat the blocked coronary vessels.

Preventive Care

You may reduce your risk of heart attack by:

  • Avoiding known risk factors like cigarette smoking or exposure to secondhand smoke.
  • Getting aerobic exercise (such as walking, biking, or swimming) for at least 3 hours per week (for example, 30 minutes 6 days per week). If you haven't exercised much in the past, walking is a great way to start.
  • Reducing stress and learning stress-reduction techniques such as deep breathing and meditation. Yoga and tai chi, two forms of exercise that emphasize stretching, breathing, and meditating, can also help you reduce your stress level.
  • Eating a low-fat diet rich in antioxidants (like carotenoids, flavonoids, vitamins C and E) as well as fiber and stay at the proper weight for your height and age.

If you have high cholesterol, diabetes, or high blood pressure, follow your health care provider's instructions to keep these risk factors under control. Often, medications are necessary in addition to lifestyle changes. If you don't have heart disease yet or have not had a heart attack despite these risk factors, aggressive control can help prevent a problem from developing. And, if you already have heart disease, aggressive control of these risk factors can prevent further heart attacks or other problems related to heart disease.

Some studies have shown that healthy individuals who consume higher amounts of folic acid (vitamin B9) and vitamin B6 are less likely to develop atherosclerosis than those who consume lower amounts of these vitamins. The American Heart Association (AHA) believes, however, that there is not yet sufficient evidence to suggest that supplementation with B vitamins reduces the risk of atheroscerlosis or that taking these supplements prevents the development or recurrence of heart disease. The AHA does not currently recommend population-wide homocysteine screening, and suggests that folic acid, as well as vitamins B6, B12, and betaine requirements be met through diet alone. Individuals at high risk for developing atherosclerosis, however, should be screened for blood levels of homocysteine. If elevated levels are detected, a healthcare practitioner may recommend supplementation (see ).

Treatment Approach

The goal when treating a heart attack is to resume blood flow to the affected area of the heart immediately. When done promptly, heart muscle tissue and function can be preserved as much as possible. Three methods for doing this are drug therapy, angioplasty (using one of several methods to clear the blocked blood vessel, such as inflating a balloon inside it or holding it open with a device called a stent), and surgery.

Once treated acutely for a heart attack, changing lifestyle factors (including making important nutritional changes) and taking medications as prescribed as well as, possibly, supplements is very important for avoiding recurrent heart attacks and even death. Certain herbal remedies as well as relaxation techniques may also be considered.


Attending cardiac rehabilitation following a heart attack can significantly improve many of your risk factors for heart disease, including high cholesterol, high blood pressure, extra weight, high homocysteine, and elevated C-reactive protein. This improvement, in turn, lowers your chances for repeat heart attacks. Cardiac rehabilitation programs generally involve comprehensive education on diet, physical activity, and relaxation with participation in a supervised exercise and stress reduction program.

To maintain the positive effects on both your risk factors and your heart, you must continue to follow the healthy habits taught in cardiac rehab, like exercise and eating properly, beyond the structured program (which usually lasts 3 months).

The AHA recommends that you eat the following to prevent the occurrence (or recurrence) of a heart attack:

  • A variety of fruits and vegetables (5 to 9 servings/day)
  • A variety of grain products, with an emphasis on whole grains (6 or more servings/day)
  • At least 2 servings of fish per week
  • Limited total fat intake to <30% and saturated fat to <7% of energy. Replace dietary saturated fats and trans fatty acids (for example, hydrogenated oils and fried foods) with monounsaturated and polyunsaturated fats (including foods rich in omega-3 fatty acids). Food sources of omega-3 fatty acids include fatty fish (such as salmon), flaxseed and flaxseed oil, soybean oil, canola oil, and nuts.
  • Limited amounts of dairy products to low-fat or fat free items (2 to 4 servings/day)
  • Limited sodium intake to 6 grams per day
  • Limited alcohol intake to 2 drinks/day for men and 1 drink/day for women
  • Maintain a healthy body weight by matching calorie intake to energy needs; this includes a moderate level of regular physical activity (30 to 60 minutes within your target heart range most days per week)


Aspirin and nitroglycerin are essential for improving blood flow. Nitroglycerin does so by widening the blocked artery, while aspirin does so by thinning the blood and preventing the formation of blood clots. Your health care provider may also prescribe one of several blood thinners listed below to improve blood flow in the blocked artery.

  • Streptokinase (SK)
  • Tissue plasminogen activator
  • Anisoylated plasminogens streptokinase activator complex—more expensive but longer anti-clotting activity than streptokinase
  • Heparin

Additional medications needed during acute treatment of a heart attack include:

  • Beta blockers—reduce cardiac rupture, new heart attacks, irregular heart beat; various side effects
  • Angiotensin-converting enzyme (ACE) inhibitors—reduce high blood pressure
  • Pain control—morphine sulfate, intravenous
  • Oxygen—by a tube inserted into your nose, as needed

After the emergent treatment of a heart attack, there are number of medications that will be continued or considered by your physician to improve your risk factors and lower your chances of having another heart attack. Cholesterol lowering drugs, beta-blockers to decrease the workload of the heart, ACE inhibitors, other blood pressure medications, and aspirin or another type of blood thinner are amongst the possible drugs he or she will recommend.

Nutrition and Dietary Supplements

In addition to the recommendations listed under Lifestyle, the AHA suggests that individuals who have heart disease follow the more specialized recommendations below, depending on what types of risk factors you have.

Diets for People with High Cholesterol

The National Cholesterol Education Program (NCEP) recommends saturated fat intake of no more than 7% of total calories, cholesterol limited to less than 200 mg/day, little to no trans fatty acids (such as fried and partially hydrogenated foods), intake of both plant stanols/sterols (2 grams/day) and soluble fiber (10 to 25 grams/day), weight loss, and exercise.

Studies have also shown that replacing dietary animal protein with soy protein may reduce total cholesterol, LDL ("bad") cholesterol, and triglycerides (a major form of fat in the blood) without affecting HDL ("good") cholesterol levels. The AHA also recommends a diet high in unsaturated fat diet rather than a very low-fat diet for individuals with a condition called "metabolic syndrome" marked by high triglycerides, low HDL cholesterol, obesity, high blood pressure, and/or diabetes).

Diets for People with High Blood Pressure

The Dietary Approaches to Stop Hypertension (DASH) emphasizes a diet rich in fruits, vegetables, and low-fat or non-fat dairy products to provide high intake of potassium, magnesium, and calcium sources. Sodium intake should be less than 6 g/day. Weight loss, regular physical activity, and limiting of alcohol intake are also very important factors for lowering blood pressure.

Mediterranean Diet

The Mediterranean Style Diet is comprised of whole grains, fresh fruits and vegetables, fish, olive oil, and moderate, daily wine consumption. Unlike the AHA diets, the Mediterranean Style Diet is not low in all fats; it is low in saturated fat but high in monounsaturated fatty acids. In a long-term study of 423 patients who suffered a heart attack, those who followed a Mediterranean Style Diet had a 50% to 70% lower risk of recurrent heart disease compared with controls who received no special dietary counseling. The intervention diet emphasized bread, root and green vegetables, daily intake of fruit, fish and poultry, olive and canola oils, margarine high in alpha-linolenic acid (an omega-3 polyunsaturated fatty acid found in flaxseed, walnuts, and canola oil), along with discouragement of ingestion of red meat and total avoidance of butter and cream.

Supplements and Vitamins


Bromelain, which has anti-inflammatory properties and antithrombotic properties (meaning that it may prevent blood clot formation), may prove to have a useful role in treating angina and preventing heart attacks.

Coenzyme Q10

Researchers believe that the beneficial effect of CoQ10 in the prevention and treatment of heart disease is due to its ability to improve energy production in cells, inhibit blood clot formation, and act as an antioxidant. One important study, for example, found that people who received daily CoQ10 supplements within 3 days of a heart attack were significantly less likely to experience subsequent heart attacks and chest pain. In addition, these same patients were less likely to die of heart disease than those who did not receive the supplements.

Folic Acid, Vitamin B6, Vitamin B12, Betaine

Many studies indicate that patients with elevated levels of the amino acid homocysteine are more likely to develop coronary artery disease. Homocysteine levels are strongly influenced by dietary factors, particularly vitamin B9 (folic acid) along with vitamin B6, vitamin B12, and betaine. Folic acid, along with these other B vitamins, breaks down homocysteine in the body. Therefore, taking a multivitamin with adequate vitamin B complex, particularly folic acid (at least 400 micrograms) can be very helpful if you have heart disease. Talk to your doctor about folic acid and the other B vitamins. Be sure to ask whether you should take folic acid or other vitamin B supplements and how much he or she thinks you should take. Some doctors recommend higher amounts of folic acid when you already have heart disease, especially if you have an elevated homocysteine level. Blood tests to follow how your homocysteine level responds to folic acid supplements may be performed. This helps determine just the right amount of folic acid for you.


Studies suggest that people who take L-carnitine supplements soon after suffering a heart attack may be less likely to have a subsequent heart attack, die of heart disease, experience chest pain and abnormal heart rhythms, or develop congestive heart failure. (Congestive heart failure is a condition that leads to a back up of blood into the lungs and legs because the heart loses its ability to pump blood efficiently).

In addition, people with coronary artery disease who use L-carnitine along with standard medications may be able to sustain physical activity for longer periods of time.


Magnesium is essential to heart health. This mineral is particularly important for maintaining a normal heart rhythm and is often used by physicians to treat an irregular heartbeat (arrythmia). Results of studies using magnesium to treat heart attack survivors, however, have been inconsistent. Some studies have reported reduced death rates as well as fewer arrythmias and improved blood pressure when magnesium is used as part of the treatment following a heart attack. But, again, not all research trials agree. In a hospital setting, if you have had a heart attack, the doctor will determine if magnesium supplementation, either intravenously or orally, is necessary.

Omega-3 Fatty Acids

There is strong evidence that omega-3 fatty acids from fatty, cold-water fish (namely EPA and DHA) can help prevent and treat atherosclerosis by inhibiting the development of plaque and blood clots. In fact, taking omega-3 fatty acid supplements every day after a heart attack may reduce your risk of a subsequent heart attack or a stroke and improve your chances for survival.

Because omega-3 fatty acids from fish oil can thin your blood, care MUST be taken if using these supplements in conjunction with blood thinners like warfarin. Talk to your doctor before using such supplements. If you are on warfarin and taking omega-3 fatty acids, your bleeding time should be followed very closely.

Other foods rich in another kind of omega-3 fatty acid called alpha-linolenic acid (ALA) are walnuts, flaxseeds, soybeans, pumpkin seeds, and flaxseed, canola (rapeseed), soybean, and walnut oils. Walnuts, and possibly other food sources of ALA, may help improve endothelial function.

Omega-3 fatty acids can also help improve certain risk factors for heart disease like high blood pressure, high cholesterol, and depression.


Low levels of selenium in your body may worsen atherosclerosis or even increase your chances for a heart attack. It is not known, however, whether selenium supplementation can prevent either a heart attack or development and progression of atherosclerosis. Although animal studies suggest that selenium might have such positive benefits, research in people is needed. Some researchers are concerned, however, that selenium supplements may minimize the benefits of cholesterol lowering drugs. Until more information is available regarding supplementation, it is best to obtain adequate amounts of selenium through your diet.

Vitamin C

Results of scientific studies regarding the benefit of vitamin C for heart disease or stroke is somewhat confusing. While not all of the studies agree, some information suggests that vitamin C may help protect blood vessels from the damaging effects that lead to or result from atherosclerosis.

For example, those with low levels of vitamin C may be more likely to have a heart attack, stroke, or peripheral artery disease. (Peripheral artery disease is the term used to describe atherosclerosis of the blood vessels to the legs. This can lead to pain with walking, known as intermittent claudication.)

In terms of damage that can cause atherosclerosis, some studies have shown that vitamin C helps prevent oxidation of LDL (bad) cholesterol (a process that contributes to plaque buildup in the arteries) as well as other negative outcomes related to oxidative stress and improve endothelial dysfunction.

Under most circumstances, dietary vitamin C is adequate for protecting against the development of or consequences from cardiovascular disease. If you have low levels of this nutrient, however, and find it difficult to obtain through dietary sources, a knowledgeable healthcare provider may recommend vitamin C supplements.

Vitamin E

Vitamin E helps prevent arteries from clogging by blocking the conversion of cholesterol into the waxy fat deposits called plaque that stick to blood vessel walls. Vitamin E also thins the blood, allowing for blood to flow more easily through arteries even when plaque is present and it may work together with other antioxidants to improve endothelial function.

Many studies over the last decade or two have reported beneficial results from use of vitamin E supplements as part of a prevention strategy for heart disease and other types of cardiovascular disease. However, four large, well-designed trials have called this practice into question. Many experts conclude, therefore, that obtaining vitamin E through dietary sources, along with other antioxidants from foods, is the way to go for preventing heart disease and its consequences. Supplements do not appear, at this time, to be necessary.


Herbs should not be used in place of IMMEDIATE medical attention for a heart attack. Herbs can be used as general heart tonics and for the treatment of conditions associated with MI, like atherosclerosis, congestive heart failure, high cholesterol levels, high blood pressure, and obesity. See the articles on these condition topics for further information.

Bilberry (Vaccinium myrtillus) and other Flavonoids

A close relative of the cranberry, bilberry fruits contain flavonoid compounds called anthocyanidins. Flavonoids are plant pigments that have excellent antioxidant properties. This means that they scavenge damaging particles in the body known as free radicals and may help prevent a number of long-term illnesses including heart disease and diabetes. Animal studies have found that anthocyanidins and other flavonoids including quercetin, resveritrol, and catechins (all found in high concentration in red wine) may strengthen blood vessels, improve circulation, and prevent the oxidation of LDL ("bad") cholesterol. Research in people is needed.

Dong Quai (Angelica sinensis)

When used in combination with ginseng (Asian ginseng) and astragalus (Astragalus membranaceus), dong quai decreased symptoms of chest pain and improved exercise tolerance in a small group of people with heart disease. Talk to your doctor about whether use is safe and appropriate for you.

Garlic (Allium sativum)

Studies suggest that fresh garlic and garlic supplements may prevent blood clots and destroy plaque. Garlic may also improve risk factors for heart disease, including high blood pressure, high cholesterol, and diabetes. An animal study suggests that garlic may help lower homocysteine levels as well. If you take aspirin or other blood thinners (like warfarin [Coumadin], ACE inhibitors (a class of blood pressure medications), sulfonylureas for diabetes, or statins for high cholesterol, talk to your doctor before using garlic supplements. Often adding garlic to your diet is enough.

Ginseng, Asian (Panax ginseng)

Ginseng is considered an adaptogen, meaning that this herb can help you and your body cope with stress. Ginseng, especially Asian ginseng, may reduce endothelial cell dysfunction, thereby rendering a heart attack less likely. Ginseng may also help raise HDL (the good cholesterol), while reducing total cholesterol levels. Ginseng may thin your blood and, therefore, should not be used with warfarin (Coumadin) unless advised and followed closely by your doctor. In addition, ginseng should NOT be used if you have high blood pressure unless specifically instructed by a qualified practitioner.

Green Tea (Camellia sinensis)

Population studies indicate that the antioxidant properties of green tea may prevent atherosclerosis, particularly in the coronary arteries. In addition, although much more research is needed, it may help you lower your cholesterol and your weight.

Gugulipid (Commiphora mukul)

Used in Ayurvedic medicine to treat high cholesterol levels. Certain ingredients in this herbal remedy may have antioxidant properties and may therefore convey health benefits similar to hawthorn, garlic, and green tea.

Hawthorn (Crataegus monogyna)

Used traditionally as a remedy for cardiovascular diseases. Animal and laboratory studies demonstrate that this herb has antioxidant properties that help protect against the formation of plaques and may help control high cholesterol and high blood pressure.

Pseudo ginseng root/notoginseng root (Panax notoginseng)

Used in Traditional Chinese Medicine to treat chest pain and coronary artery disease. Laboratory studies suggest this herb may help prevent blood clots and protect against the formation of plaques.

Turmeric (Curcuma longa)

Early studies suggest that turmeric may prove helpful in preventing the build up of atherosclerosis in one of two ways. First, in animal studies an extract of turmeric lowered cholesterol levels and inhibited the oxidation of LDL ("bad") cholesterol. Oxidized LDL deposits in the walls of blood vessels and contributes to the formation of atherosclerotic plaque and to disruption of the blood vessel wall.

Turmeric may also prevent platelet build up along the walls of an injured blood vessel. Platelets collecting at the site of a damaged blood vessel cause blood clots to form and blockage of the artery. Studies of the use of turmeric to prevent or treat heart disease in people would be interesting in terms of determining if these mechanisms discovered in animals apply to people at risk for this condition.


Homeopathy should NEVER be used instead of immediate medical attention for a heart attack. Homeopathy may, however, be used to help reduce your risk factors for heart disease and its consequences. Although few studies have examined the effectiveness of specific homeopathic remedies, professional homeopaths would recommend appropriate therapy to lower high blood pressure and cholesterol. Before prescribing a remedy, homeopaths take into account your constitutional type. In homeopathic terms, a person's constitution is his or her physical, emotional, and intellectual makeup. An experienced homeopath would assess all of these factors when determining the most appropriate remedy for you as an individual.


Acupuncture may be useful for reducing risk factors for heart disease. It is considered an excellent treatment for people who wish to quit smoking and some studies indicate that it may aid in weight loss as well as cholesterol and blood pressure reduction. Acupuncture may also help you recover more quickly from a heart attack, particularly if by pass surgery was necessary.

Massage and Physical Therapy

Although few studies have examined the effectiveness of massage therapy for heart disease, massage has a relaxing effect and reduces stress-related hormone levels. Lowering stress hormone levels can lower cholesterol and blood pressure and may, therefore, prove to be beneficial for reducing your risk of heart disease. In addition, relaxation techniques may help you comply with habits necessary to reduce the risk of heart disease, such as dieting, quitting smoking, and exercising. Also, at least one study has found that massage can lower blood pressure.

Mind/Body Medicine

There is some evidence that the use of prayer may help you recover more quickly and successfully from a heart attack. In fact, a few studies conducted suggest that you don't have to be the one praying. Others, even people you don't know, praying for you may translate into clinical benefit. This is called intercessory prayer or distance healing.

Other Considerations
Prognosis and Complications

The expected outcome varies with the amount and location of damaged tissue. The outcome is worse if there is damage to the electrical conduction system (the impulses responsible for guiding heart contraction).

Heart attack accounts for 1 out of every 5 deaths. It is a major cause of sudden death in adults. Approximately one-third of heart attacks are fatal. If the person is alive 2 hours after an attack, the probable outcome for survival is good, but may include complications such as:

  • Irregular heart rhythm, called an arrhythmia; this may increase your chances for sudden death and may require electrical cardioversion or placement of a device to protect you from sudden death or a pacemaker to direct the electrical system of your heart.
  • Congestive heart failure
  • Shock
  • Infarct extension (extension of the amount of affected heart tissue) or recurrent heart attack(s)
  • Pericarditis (infection around the lining of the heart)
  • Pulmonary embolism (blood clot in the lungs)
  • Complications of treatment (For example, thrombolytic agents increases the risk of bleeding.)

The good news, however, is that heart attacks are not necessarily disabling, especially when there are no complications. In fact, full recovery is possible including resumption of a normal lifestyle and usual activities, even sexual activity. Cardiac rehabilitation and sticking with lifestyle changes can help lead to a positive recovery.

Supporting Research

Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol. 2003;92(6):665-669.

Abrams J. C-reactive protein, inflammation, and coronary risk: an update. Cardiol Clin. 2003;21(3):327-331.

Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med. 2001;161:813-824.

Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279(1):23-28.

Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit. 2003;9(1):RA9-18.

Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev. 2003;8(1):71-86.

Angerer P, von Schacky C. n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol. 2000;11(1):57-63.

Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz. 2003;28(7):628-638.

Arnow WS. C-reactive protein. Should it be considered a coronary risk factor? Geriatrics. 2003;58(5):19-22,25.

Arsenian, MA. Carnitine and its derivatives in cardiovascular disease. Progr Cardiovasc Dis. 1997;40:3:265-286.

Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr. 2001;131(11):2932-2935.

Bahorun T, Trotin F, Pommery J, Vasseur J, Pinkas M. Antioxidant activities of Crataegus monogyna extracts. Planta Med. 1994;60:323-328.

Bahrke MS, Morgan WR. Evaluation of the ergogenic properties of ginseng: an update. Sports Med. 2000;29(2):113-133.

Barefoot JC, Burg MM, Carney RM, et al. Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil. 2003;23(6):404-412.

Berman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infacrction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289(23):3106-3116.

Berthold HK, Sudhop T. Galic preparation for prevention of atherosclerosis. Curr Opin Lipidol. 1998;9(6):565-569.

Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism. JAMA. 1998;279.

Blake GJ. Inflammatory biomarkers of the patient with myocardial insufficiency. Curr Opin Crit Care. 2003;9(5):369-374.

Blumenthal JA, O'Connor C, Hinderliter A, et al. Psychosocial factors and coronary disease. A national multicenter clinical trial (ENRICHD) with a North Carolina focus. NC MED J. 1997;58(6):440-444.

Buckley MS, Goff AD, Knapp, WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004;38(1):50-52.

Carney RM, Blumenthal JA, Catellier D, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003;92(11):1277-1281.

Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Bio Pharm. 2000;60(10):1539-1548.

Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary heart disease and low HDL. Arterioscler Thromb Vasc Biol. 2001;21(8):1320-1326.

Chiu YJ, Chi A, Reid IA. Cardiovascular and endocrine effects of acupuncture in hypertensive patients. Clin Exper Hypertens. 1997;19(7):1047-1063.

Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;357:89-95.

Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr. 1997;66(suppl):1020S-1031S.

Curcuma longa (turmeric). Monograph. Altern Med Rev. 2001;6 Suppl:S62-S66.

de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-1459.

de Logeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-785.

Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337(16):408-416.

Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131:363-375.

Elgharib N, Chi DS, Younis W, Wehbe S, Krishnaswamy G. C-reactive protein as a novel biomarker. Reactant can flag atherosclerosis and help predict cardiac events. Postgrad Med. 2003;114(6):39-44; quiz 16.

Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3(3):194-202.

Erbs S, Gielen S, Linke A, et al. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J. 2003;146(2):280-285.

Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.

Fatty fish consumption and ischemic heart disease mortality in older adults: The cardiovascular heart study. Presented at the American Heart Association's 41st annual conference on cardiovascular disease epidemiology and prevention. AHA. 2001.

FDA Talk Paper. T99-48. FDA approves new health claim for soy protein and coronary heart disease. October 20, 1999.

Filshie J, White A. The clinical use of, and evidence for, acupuncture in the medical systems. In: Filshie J, White A, eds. Medical Acupuncture: A Western Scientific Approach. Edinburgh, UK: Churchill-Livingstone; 1998:234-236.

Frasure-Smith N, Lesperance F. Depression - a cardiac risk factor in search of a treatment. JAMA. 2003;289(23):3171-3173.

Fugh-Berman A. Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Prev Cardiology. 2000;3:24-32.

Fung TT, Hu FB. Plant-based diets: what should be on the plate? Am J Clin Nutr. 2003;78(3):357-358.

Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JCM. Tea flavonoids may protect against atherosclerosis: the Rotterdam study. Arch Intern Med. 1999;159:2170-2174.

Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75(5):880-886.

GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.

Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709.

Gokce N, Keaney JF, Frei B, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999;99:3234-3240.

Gonzales MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003; 115 Suppl 8A:99S-106S.

Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol. 2003;41(7);1205-1210.

Grant PJ. The genetics of atherothrombotic disorders: a clinician's view. J Thromb Haemost. 2003;1(7):1381-1390.

Guo H, Lee JD, Ueda T, Cheng J, Shan J, Wang J. Hyperhomocysteinaemia and folic acid supplementation in patients with high risk of coronary artery disease. Indian J Med Res. 2004;119:33-37.

Guo H, Lee JD, Ueda T, Shan J, Wang J. Plasma homocysteine levels in patients with early coronary artery stenosis and high risk factors. Jpn Heart J. 2003;44(6):865-871.

Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Manson J. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation. 2003;108(7):802-807.

Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 2001;161(18):2185-2192.

Harris WS, Gowda M, Kolb JW, et al. A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit. Arch Intern Med. 1999;159(19):2273-2278.

Heart Prtoection Study Collaborative Group. MRC/BHF heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23-33.

Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221-1227.

Heinecke JW. Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis? Curr Atheroscler Rep. 2003;5(2):83-87.

Hernandez-Reif M, Field T, Krasnegor J, Theakston H, Hossain Z, Burman I. High blood pressure and associated symptoms were reduced by massage therapy. J Bodywork Movement Ther. 2000; 4:31-38

Higgins JP. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Mayo Clin Proc. 2003;78(3):321-332.

Hu FB, Stampfer MJ, Manson JE et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890-897.

Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995;26:380.

ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captropril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345(8951):669-685.

Kelly GS. L-Carnitine: therapeutic applications of a conditionally-essential amino acid. Alt Med Rev. 1998;3:345-60.

Kelly GS. Nutritional and botanical interventions to assist with the adaptation to stress. Alt Med Rev. 1999;4(4):249-265.

Kendler BS. Recent nutritional approaches to the prevention and therapy of cardiovasular disease. Prog Cardiovasc Nurs. 1997;12(3):3-23.

Kinlay S, Behrendt D, Fang JC, et al. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004;43(4):629-634.

Klevay LM, Milne DB. Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr. 2002;75(3):550-554.

Koh KB, Choe KO, An SK. Anger and coronary calcification in individuals with and without risk factors of coronary artery disease. Yonsei Med J. 2003;30:44(5):793-799.

Koenig W. Inflammation and coronary heart disease: an overview. Cardiol Rev. 2001;9(1):31-35.

Koscielny J, Klubendorf D, Latza R, Schmitt R, Radtke H, Siegel G, Kiesewetter H. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999;144:237-249.

Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA Scientific Statement: AHA dietary guidelines revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102(18):2284-2299.

Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzare TL. AHA science advisory: Lyon diet heart study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I dietary pattern on cardiovascular disease. Circulation. 2001;103:1823-1825.

Kruzel T. The Homeopathic Emergency Guide. Berkeley, Calif: North Atlantic Books; 1992:58-60.

Kurono Y, Egawa M, Yano T, Shimoo K. The effect of acupuncture on the coronary arteries as evaluated by coronary angiography: a preliminary report. Am J Chin Med. 2002;30(2-3):387-396.

Langsjoen P, Langsjoen A. Overview of the use of CoQ10 in cardiovascular disease. BioFactors. 1999;9:273-284.

Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations. Fundam Clin Pharmacol. 1997;11(1):35-40.

Lee BJ, Lin PT< Liaw YP, Chang SJ, Cheng CH, Huang YC. Homocysteine and risk of coronary arter disease: Folate is the important determinant of plasma homocysteine concentration. Nutrition. 2003;19(7-8):577-583.

Lefevre M, Kris-Etherton PM, Zhao G, Tracy RP. Dietary fatty acids, hemostasis, and cardiovascular disease risk. J Am Diet Assoc. 2004;104(3):410-419, quiz 492.

Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney FJ, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113.

Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol. 2003;41(12):2105-2113.

Linton MF, Fazio S; National Cholesterol Education Program (NCEP)-the third Adult Treatment Panel (ATP III). Am J Cardiol. 2003;92(1A):19i-26i.

Little D. An intervention to treat depression and increase social support did not prolong event-free survival in coronary heart disease. ACP J Club. 2004;140(1):8.

Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patienst with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25(11):1919-1927.

Loster H, Miehe K, Punzel M, Stiller O, Pankau H, Schauer J. Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency. Cardiovasc Drugs Ther. 1999;13:537-546.

Loy MH, Rivlin RS. Garlic and cardiovascular disease. Nutr Clin Care. 2000;3(3):146-151.

Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet, and cardiovascular disease. A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation. 1999;99:178-182.

Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein (a) and Cardiovascular Disease: recent advances and future directions. Clin Chem. 2003;49(11):1785-1796.

Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease. Arch Intern Med. 1998;158:2225-2234.

Matetzky S, Freimark DD, Ben-Ami S, et al. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction. Arch Intern Med. 2003;163(16):1933-1937.

Maurer HR. Bromelain: biochemistry, pharmacology, and medical use. Cell Mol Life Sci. 2001;58(9):1234-1245.

McKenna DJ, Hughes K, Jones K. Green tea monograph. Alt Ther. 2000;6(3):61-84.

Mendes de Leon CF, Dilillo V, Czajkowski S, et al. Enhancing Recovery in Coronary Heart Disease (ENRICHD) Pilot Study. Psychosocial characteristics after acute myocardial infarction: the ENRICHD pilot study. Enhancing Recovery in Coronary Heart Disease. J Cardiopulm Rehabil. 2001;21(6):353-362.

Meydani M. Omega-3 fatty acids alter soluble markers of endothelial function in coronary heart disease patients. Nutr Rev. 2000;58(2 pt 1):56-59.

Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004;43(6):1056-1061.

Miller AL. Botanical influences on cardiovascular disease. Altern Med Review. 1998;3(6):422-431.

Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131(1):27-32.

Meagher EA. Treatment of atherosclerosis in the new millennium: is there a role for vitamin E? Prev Cardiol. 2003;6(2):85-90.

Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease. Cardiol Clin. 2003;21(3):333-362.

Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108(15):1772-1778.

Negri E, La Vecchia C, Pelucchi C, Bertuzzi M, Tavani A. Fiber intake and risk of nonfatal acute myocardial infarction. Eur J Clin Nutr. 2003;57(3):464-470.

Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ. 1997;314:634-638.

Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willet WC. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr. 2003;77(6):1390-1399.

Prasad K. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132(1):69-76.

Price JR. Treating low perceived social support and depression after myocardial infarction does not increase event-free survival. Evid Based Ment Health. 2004;7(1):22.

Pruthi S, Allison TG, Hensrud DD. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin Proc. 2001;76:1131-1136.

Rahman K. Historical perspective on garlic and cardiovascular disease. J Nutr. 2001;131(3s):977S-979S.

Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999;147(2):371-378.

Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health. Crit Rev Food Sci Nutr. 2002;42(3 Suppl):301-316.

Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm. 2002;59(5):417-422.

Rimm EB, Stampfer MJ, Ascherio A, Giovannucii E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. NEJM. 1993;328(20):1450-1456.

Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279:359-364.

Roberts L, Ahmed I, Hall S. Intercessory prayer for the alleviation of ill health. Cochrane Database Syst Rev. 2000;(2):CD000368.

Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation. 1998;97:437-443.

Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol. 2003;23(5):885-891.

Roe E, Nunez I, Perez-Heras A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects.Circulation. 2004;109(13):1609-1614.

Rosenson RS, Koenig W. Utility of inflammatory markers in the management of coronary artery disease. Am J Cardiol. 2003;92(1A):10i-18i.

Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia, PA: Hanley & Belfus, Inc; 2002:231-235.

Ruburg FL, Leooplold JA, Loscalzo J. Atheothrombosis: plaque instability and thrombogenesis. Prog Cardiovasc Dis. 2002;44(5):381-394.

Sasazuki S, Kodama H, Yoshimasu K et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000;10:401-408.

Serebruany VL, Ordonez JV, Herzog WR, et al. Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression. J Cardiovasc Pharmacol. 1997;29:16-22.

Scanu AM. Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. Curr Atheroscler Rep. 2003;5(2):106-113.

Schussler M, Holzl J, Fricke U. Myocardial effects of flavonoids from crataegus species. Arzneimittelforschung. 1995;45:842-845.

Shah SH, Newby LK. C-reactive protein: a novel marker of cardiovascular risk. Cardiol Rev. 2003;11(4):169-179.

Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? Am J Cardiovasc Drugs. 2003;3(4):231-239.

Sheps DS, Freedland KE, Golden RN, et al. ENRICHD and SADHART: implications for future biobehavioral intervention efforts. Psychosom Med. 2003;65(1):1-2.

Silagy CA, Neil AW. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994;12:463-468.

Simon JA, Murtaugh MA, Gross MD, Loria CM, Hulley SB, Jacobs DR Jr. Relation of ascorbic acid to coronary artery calcium: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol. 2004;159(6):581-588.

Singh RB, Neki NS, Kartikey K, et al. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem. 2003;246(1-2):75-82.

Singh RB, Niaz MA, Agarwal P, et. al. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med. 1996;72:45-50.

Singh RB, Niaz MA, Agarwal P, et. al. Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc. 1995;95:775-780.

Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction. Int J Clin Pharmacol Thera. 1996;34:219-225.

Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-353.

Sobczak AJ. The effects of tobacco smoke on the homocysteine level - a risk factor of therosclerosis. Addict Biol. 2003;8(2):147-158.

Soltero-Perez IF. Thinking intelligently about therpy of atherosclerosis. Am J Ther. 2003;10(6):429-437.

Spigelski D, Jones PJ. Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutr Rev. 2001;59(7):236-241.

Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. NEJM. 2000;343(1):16-22.

Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. Ann Intern Med. 2000;133(6):420-429.

Strike PC, Steptoe A. Psychosocial facotrs in the development of coronary artery disease. Prog Cardiovasc Dis. 2004;46(4):337-347.

Sum CF, Winocour PH, Agius L, et al. Does oral L-carnitine alter plasma triglyceride levels in hypertriglyceridemic subjects with or without non-insulin dependent diabetes mellitus. Diabetes Nutr Metab Clin Exp. 1992;5:175-181.

Sung J, Han KH, Zo JH, Park HJ, Kim CH, Oh B-H. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med. 2000;28(2):205-216.

Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol. 2000;35(2):321-326.

Tanguy S, Toufektsian MC, Besse S, Ducros V, De Leiris J, Boucher F. Dietary selenium intake affects cardiac susceptibility to ischaemia/reperfusion in male senescent rats. Age Ageing. 2003;32(30:273-278.

Tokmakidis SP, Volaklis KA. Training and detraining effects of a combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease. J Cardiopulm Rehabil. 2003;23(3):193-200.

Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart. 2003;89(9):993-997.

Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2000;34(12):1478-1482.

Valgimigli M, Merli E, Malagutti P, et al. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. Arch Biochem Biophys. 2003;420(2):255-261.

Vermeulen EGJ, Stehouwer CDA, Twisk JWR, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet. 2000;355:517-522.

Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infaction and fatal coronary heart disease. Arch Intern Med. 1998;158:668-675.

Von Schacky C, Angere P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. Ann Intern Med. 1999;130:554-562.

Wang HX, NG TB. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci. 1999;65(25):2663-2677.

Watkins LL, Schneiderman N, Blumenthal JA, et al. Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J. 2003;146(1):48-54.

Yang TTC, Koo MWI. Chinese green tea lowers cholesterol level through an increase in fecal lipid excreiton. Life Sci. 1999:66:5:411-423.

Yeh ET, Palusinski RP. C-reactive protein: the pawn has been promoted to queen. Curr Atheroscler Rep. 2003;5(2):101-105.

Yologlu S, Sezgin AT, Ozdemir R, et al. Identifying risk factors in a mostly overweight patient population with coronary artery disease. Angiology. 2003;54(2):181-186.

Yoshizawa K, Ascherio A, Morris JS, et al. Prospective study of selsnium levels in toenails and risk of coronary heart disease in men. Am J Epidemiol. 2003;158(9):852-860.

Zambón D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. Ann Intern Med. 2000;132:538-546.

Review Date: April 2004
Reviewed By: Participants in the review process include: Jacqueline A. Hart, MD, Department of Internal Medicine, Division of Cardiac Rehabilitation, Newton-Wellesley Hospital, Newton, Ma., and Senior Medical Editor, A.D.A.M., Inc.; Lonnie Lee, MD, Internal Medicine, Silver Springs, MD; Richard A. Lippin, MD, President, The Lippin Group, Southampton, PA.

Copyright © 2004 A.D.A.M., Inc

The publisher does not accept any responsibility for the accuracy of the information or the consequences arising from the application, use, or misuse of any of the information contained herein, including any injury and/or damage to any person or property as a matter of product liability, negligence, or otherwise. No warranty, expressed or implied, is made in regard to the contents of this material. No claims or endorsements are made for any drugs or compounds currently marketed or in investigative use. This material is not intended as a guide to self-medication. The reader is advised to discuss the information provided here with a doctor, pharmacist, nurse, or other authorized healthcare practitioner and to check product information (including package inserts) regarding dosage, precautions, warnings, interactions, and contraindications before administering any drug, herb, or supplement discussed herein.

  Conditions with Similar Symptoms
View Conditions
ACE Inhibitors
Blood Pressure Medications
Blood-thinning Medications
Blood-thinning Medications, Anticoagulants
Blood-thinning Medications, Antiplatelets
Blood-thinning Medications, Thrombolytics
Cholesterol-lowering Medications
Heart Medications
Morphine Sulfate
Pain Relievers (Analgesics)
Asian Ginseng
Dong Quai
Green Tea
Alpha-Linolenic Acid (ALA)
Carnitine (L-Carnitine)
Coenzyme Q10
Docosahexaenoic Acid (DHA)
Eicosapentaenoic Acid (EPA)
Flaxseed Oil
Omega-3 Fatty Acids
Vitamin B12 (Cobalamin)
Vitamin B6 (Pyridoxine)
Vitamin B9 (Folic Acid)
Vitamin C (Ascorbic Acid)
Vitamin E
  Related Articles
View Articles
  Learn More About
Herbal Medicine
Mind/Body Medicine
Relaxation Techniques

Home | Store Locations | Buy Online | Store Specials | About Us | Delicious Living | Reference Library | News & Features | Health Tools | Treatment Options | Healthy Recipes | Ingredient Glossary | My Account | Contact Us | Help | Shopping Cart | Privacy Policy | Terms of Use |

Powered By Living Naturally